NanoMab Technology (UK) Limited
1 clinical trials · Sponsor
◉ Watch NanoMab Technology (UK) Limited
| Record | Firm | Date |
|---|---|---|
| PD-L1 Expression in Lung Cancer (NCT04992715) | NanoMab Technology (UK) Limited | 2022-05-03 |
Track NanoMab Technology (UK) Limited automatically
Every clearance here is in the API, with alerts when new ones post.